Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi

Overview of attention for article published in Frontiers in oncology, March 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

So far, Dimensions has found 514 publications that cite this research output.

Preprint in Research Square (May 2024)

Article in Frontiers in Oncology (May 2024)

Article in Oncogene (May 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.